allogeneic fibroblasts
Cell therapyexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Jul 31, 2005 (NCT00232973)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07219654 | Phase 2 | Nov 30, 2025 | Tego Science, Inc. |
| NCT06533540 | Phase 1 | Dec 31, 2024 | Tego Science, Inc. |
| NCT06414005 | Phase 2/Phase 3 (Phase 3) | Apr 15, 2024 | Seoul National University, Tego Science, Inc. |
| NCT06197789 | Phase 3 | Aug 18, 2021 | Kyungpook University, Tego Science, Inc. |
| NCT04470167 | Phase 1/Phase 2 (Phase 2) | Oct 26, 2020 | Seoul National University, Tego Science, Inc. |
| NCT00232973 | Phase 3 | Jul 31, 2005 | Intercytex |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tego Science, Inc. | For profit | 5 | 5 | 3 | 2020 |
| Seoul National University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Intercytex | For profit | 1 | 1 | 1 | 2005 |
| Kyungpook University | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1